Open AccessBoceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
Author(s) -
Isakov Va,
И. Г. Никитин,
Vladimir Chulanov,
П. П. Огурцов,
E. G. Lukyanova,
Jianmin Long,
Janice Wahl,
F.A. Helmond
Publication year - 2016
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v8.i6.331
Subject(s) - boceprevir , medicine , ribavirin , gastroenterology , hepatitis c virus , clinical endpoint , placebo , telaprevir , hepatitis c , randomized controlled trial , immunology , virus , pathology , alternative medicine
To evaluate addition of boceprevir to peginterferon/ribavirin (PR) in Russian patients with chronic hepatitis C virus (HCV).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom